CRVS
Corvus Pharmaceuticals Inc
12.40$
-1.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +301.4% | +41.8% | +0.6% | -12.3% | -14.9% | -27.2% | -20.2% | -58.9% | -43.7% | +23.5% | |
| – | – | +794.4% | +62.7% | +14.5% | +3.0% | -21.8% | -26.4% | -36.4% | -20.2% | +39.9% | +77.5% | |
| – | +0.0% | -75.2% | +34.8% | +18.2% | +3.0% | -526.3% | – | – | – | – | – | |
| – | +20,892.3% | +88.2% | -25.3% | -155.3% | – | +0.3% | -269.5% | – | -354.5% | – | – | |
| – | +0.0% | +25.9% | -87.9% | +33.5% | -93.0% | +204.0% | -93.4% | +5,280.0% | -87.4% | -100.0% | – | |
| – | +0.0% | -53.8% | – | -135.6% | – | +1,275.4% | -51.8% | -208.0% | – | -276.8% | -71.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4,384,730.4% | -25.4% | -98.0% | +4,426.4% | -100.0% | +5,266.7% | – | – | – | – | – | |
| – | +590.0% | -24.8% | -98.0% | +4,426.4% | -100.0% | +5,358.3% | +4,644.9% | -100.0% | +43,538.9% | +524.2% | -25.7% | |
| – | -161.6% | – | +4,138.7% | -114.8% | – | – | +315.9% | -207.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.